275 related articles for article (PubMed ID: 17999504)
1. Design, synthesis, and characterization of a potent, nonpeptide, cell-permeable, bivalent Smac mimetic that concurrently targets both the BIR2 and BIR3 domains in XIAP.
Sun H; Nikolovska-Coleska Z; Lu J; Meagher JL; Yang CY; Qiu S; Tomita Y; Ueda Y; Jiang S; Krajewski K; Roller PP; Stuckey JA; Wang S
J Am Chem Soc; 2007 Dec; 129(49):15279-94. PubMed ID: 17999504
[TBL] [Abstract][Full Text] [Related]
2. Design and characterization of bivalent Smac-based peptides as antagonists of XIAP and development and validation of a fluorescence polarization assay for XIAP containing both BIR2 and BIR3 domains.
Nikolovska-Coleska Z; Meagher JL; Jiang S; Kawamoto SA; Gao W; Yi H; Qin D; Roller PP; Stuckey JA; Wang S
Anal Biochem; 2008 Mar; 374(1):87-98. PubMed ID: 18023397
[TBL] [Abstract][Full Text] [Related]
3. Interaction of a cyclic, bivalent smac mimetic with the x-linked inhibitor of apoptosis protein.
Nikolovska-Coleska Z; Meagher JL; Jiang S; Yang CY; Qiu S; Roller PP; Stuckey JA; Wang S
Biochemistry; 2008 Sep; 47(37):9811-24. PubMed ID: 18717598
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for bivalent Smac-mimetics recognition in the IAP protein family.
Cossu F; Milani M; Mastrangelo E; Vachette P; Servida F; Lecis D; Canevari G; Delia D; Drago C; Rizzo V; Manzoni L; Seneci P; Scolastico C; Bolognesi M
J Mol Biol; 2009 Sep; 392(3):630-44. PubMed ID: 19393243
[TBL] [Abstract][Full Text] [Related]
5. Structural insight into inhibitor of apoptosis proteins recognition by a potent divalent smac-mimetic.
Cossu F; Milani M; Vachette P; Malvezzi F; Grassi S; Lecis D; Delia D; Drago C; Seneci P; Bolognesi M; Mastrangelo E
PLoS One; 2012; 7(11):e49527. PubMed ID: 23166698
[TBL] [Abstract][Full Text] [Related]
6. Requirement of both the second and third BIR domains for the relief of X-linked inhibitor of apoptosis protein (XIAP)-mediated caspase inhibition by Smac.
Huang Y; Rich RL; Myszka DG; Wu H
J Biol Chem; 2003 Dec; 278(49):49517-22. PubMed ID: 14512414
[TBL] [Abstract][Full Text] [Related]
7. A dimeric Smac/diablo peptide directly relieves caspase-3 inhibition by XIAP. Dynamic and cooperative regulation of XIAP by Smac/Diablo.
Gao Z; Tian Y; Wang J; Yin Q; Wu H; Li YM; Jiang X
J Biol Chem; 2007 Oct; 282(42):30718-27. PubMed ID: 17724022
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and evaluation of monovalent Smac mimetics that bind to the BIR2 domain of the anti-apoptotic protein XIAP.
González-López M; Welsh K; Finlay D; Ardecky RJ; Ganji SR; Su Y; Yuan H; Teriete P; Mace PD; Riedl SJ; Vuori K; Reed JC; Cosford ND
Bioorg Med Chem Lett; 2011 Jul; 21(14):4332-6. PubMed ID: 21680182
[TBL] [Abstract][Full Text] [Related]
9. Design of small-molecule peptidic and nonpeptidic Smac mimetics.
Sun H; Nikolovska-Coleska Z; Yang CY; Qian D; Lu J; Qiu S; Bai L; Peng Y; Cai Q; Wang S
Acc Chem Res; 2008 Oct; 41(10):1264-77. PubMed ID: 18937395
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a heterodimeric Smac-based peptide that features sequences specific to both the BIR2 and BIR3 domains of the X-linked inhibitor of apoptosis protein.
Speer KF; Cosimini CL; Splan KE
Biopolymers; 2012; 98(2):122-30. PubMed ID: 22020922
[TBL] [Abstract][Full Text] [Related]
11. Structure-based design, synthesis, evaluation, and crystallographic studies of conformationally constrained Smac mimetics as inhibitors of the X-linked inhibitor of apoptosis protein (XIAP).
Sun H; Stuckey JA; Nikolovska-Coleska Z; Qin D; Meagher JL; Qiu S; Lu J; Yang CY; Saito NG; Wang S
J Med Chem; 2008 Nov; 51(22):7169-80. PubMed ID: 18954041
[TBL] [Abstract][Full Text] [Related]
12. A NMR and computational study of Smac mimics targeting both the BIR2 and BIR3 domains in XIAP protein.
Potenza D; Belvisi L; Vasile F; Moroni E; Cossu F; Seneci P
Org Biomol Chem; 2012 Apr; 10(16):3278-87. PubMed ID: 22407164
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs.
Zobel K; Wang L; Varfolomeev E; Franklin MC; Elliott LO; Wallweber HJ; Okawa DC; Flygare JA; Vucic D; Fairbrother WJ; Deshayes K
ACS Chem Biol; 2006 Sep; 1(8):525-33. PubMed ID: 17168540
[TBL] [Abstract][Full Text] [Related]
14. Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.
Vucic D; Franklin MC; Wallweber HJ; Das K; Eckelman BP; Shin H; Elliott LO; Kadkhodayan S; Deshayes K; Salvesen GS; Fairbrother WJ
Biochem J; 2005 Jan; 385(Pt 1):11-20. PubMed ID: 15485396
[TBL] [Abstract][Full Text] [Related]
15. Theoretical studies on the interactions of XIAP-BIR3 domain with bicyclic and tricyclic core monovalent Smac mimetics.
Ling B; Dong L; Zhang R; Wang Z; Liu Y; Liu C
J Mol Graph Model; 2010 Nov; 29(3):354-62. PubMed ID: 20980180
[TBL] [Abstract][Full Text] [Related]
16. Rational design, synthesis and characterization of potent, non-peptidic Smac mimics/XIAP inhibitors as proapoptotic agents for cancer therapy.
Seneci P; Bianchi A; Battaglia C; Belvisi L; Bolognesi M; Caprini A; Cossu F; Franco Ed; Matteo Md; Delia D; Drago C; Khaled A; Lecis D; Manzoni L; Marizzoni M; Mastrangelo E; Milani M; Motto I; Moroni E; Potenza D; Rizzo V; Servida F; Turlizzi E; Varrone M; Vasile F; Scolastico C
Bioorg Med Chem; 2009 Aug; 17(16):5834-56. PubMed ID: 19620011
[TBL] [Abstract][Full Text] [Related]
17. Designing Smac-mimetics as antagonists of XIAP, cIAP1, and cIAP2.
Cossu F; Mastrangelo E; Milani M; Sorrentino G; Lecis D; Delia D; Manzoni L; Seneci P; Scolastico C; Bolognesi M
Biochem Biophys Res Commun; 2009 Jan; 378(2):162-7. PubMed ID: 18992220
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design and molecular profiling of Smac-mimetics selective for cellular IAPs.
Corti A; Milani M; Lecis D; Seneci P; de Rosa M; Mastrangelo E; Cossu F
FEBS J; 2018 Sep; 285(17):3286-3298. PubMed ID: 30055105
[TBL] [Abstract][Full Text] [Related]
19. Targeting the X-linked inhibitor of apoptosis protein through 4-substituted azabicyclo[5.3.0]alkane smac mimetics. Structure, activity, and recognition principles.
Mastrangelo E; Cossu F; Milani M; Sorrentino G; Lecis D; Delia D; Manzoni L; Drago C; Seneci P; Scolastico C; Rizzo V; Bolognesi M
J Mol Biol; 2008 Dec; 384(3):673-89. PubMed ID: 18851976
[TBL] [Abstract][Full Text] [Related]
20. Bivalent SMAC Mimetics for Treating Cancer by Antagonizing Inhibitor of Apoptosis Proteins.
Zhu H; Li Y; Liu Y; Han B
ChemMedChem; 2019 Dec; 14(23):1951-1962. PubMed ID: 31692274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
